Nanobiotix Ownership | Who Owns Nanobiotix?


OverviewForecastRevenueFinancialsChartTranscripts

Nanobiotix Ownership Summary


Nanobiotix is owned by 13.62% institutional investors, and 86.38% retail investors. Johnson & johnson is the largest institutional shareholder, holding 15.23% of NBTX shares. Baillie Gifford Global Discovery A Acc is the top mutual fund, with 3.24% of its assets in Nanobiotix shares.

NBTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNanobiotix13.62%-86.38%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Johnson & johnson5.62M15.23%$28.12M
Perceptive advisors555.07K1.50%$2.78M
Blackrock239.01K0.65%$1.20M
Ubs group3.10K0.01%$15.50K
Bank of america corp /de/760.000.00%$3.80K
Royal bank of canada263.000.00%$1.00K
Barclays110.000.00%$1.00K
Rhumbline advisers33.000.00%$165.00
Morgan stanley2.00-$10.00
Tower research capital llc (trc)---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Johnson & johnson5.62M7.02%$28.12M
Perceptive advisors555.07K0.07%$2.78M
Tower research capital llc (trc)---
Barclays110.00-$1.00K
Bank of america corp /de/760.00-$3.80K
Rhumbline advisers33.00-$165.00
Ubs group3.10K-$15.50K
Royal bank of canada263.00-$1.00K
Qube research---
Baillie gifford---

Top Buyers

HolderShares% AssetsChange
Bank of america corp /de/760.00-498.00
Royal bank of canada263.00-263.00
Barclays110.00-110.00
Perceptive advisors555.07K0.07%-
Rhumbline advisers33.00--

Top Sellers

HolderShares% AssetsChange
Baillie gifford---2.87M
Blackrock239.01K--14.45K
Tower research capital llc (trc)---450.00
Qube research---343.00
Rhumbline advisers33.00--

New Positions

HolderShares% AssetsChangeValue
Barclays110.00-110.00$1.00K

Sold Out

HolderChange
Qube research-343.00
Tower research capital llc (trc)-450.00
Baillie gifford-2.87M

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202410-16.67%6,418,032-30.94%133.50%3-25.00%1-50.00%
Jun 30, 202411-9,291,531-0.17%253.57%3-40.00%2100.00%
Mar 31, 202411-8.33%9,306,9820.38%263.75%5-28.57%1-66.67%
Dec 31, 20231233.33%9,271,461107.49%2616.18%716.67%350.00%
Sep 30, 2023980.00%4,468,33829.00%1212.98%6200.00%2-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Baillie Gifford Global Discovery A Acc1.54M3.24%8.29K
Edinburgh Worldwide Ord1.34M2.83%-
iShares Biotechnology ETF220.78K0.47%-1.32K
Fidelity Nasdaq Composite Index5.81K0.01%-

NBTX Ownership FAQ


Who Owns Nanobiotix?

Nanobiotix shareholders are primarily institutional investors at 13.62%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Nanobiotix's industry, Biotech Stocks , is 47.04%, which Nanobiotix falls below.

Who owns the most shares of Nanobiotix?

Nanobiotix’s largest shareholders are Johnson & johnson (5.62M shares, 15.23%), Perceptive advisors (555.07K shares, 1.50%), and Blackrock (239.01K shares, 0.65%). Together, they hold 17.38% of Nanobiotix’s total shares outstanding.

Does Blackrock own Nanobiotix?

Yes, BlackRock owns 0.65% of Nanobiotix, totaling 239.01K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.2M$. In the last quarter, BlackRock decreased its holdings by -14.446K shares, a -5.70% change.

Who is Nanobiotix’s biggest shareholder by percentage of total assets invested?

Johnson & johnson is Nanobiotix’s biggest shareholder by percentage of total assets invested, with 7.02% of its assets in 5.62M Nanobiotix shares, valued at 28.12M$.

Who is the top mutual fund holder of Nanobiotix shares?

Baillie Gifford Global Discovery A Acc is the top mutual fund holder of Nanobiotix shares, with 3.24% of its total shares outstanding invested in 1.54M Nanobiotix shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools